Literature DB >> 31056949

Adverse events associated with weight-based, high-dose montelukast exposures in children.

Donald H Arnold1,2,3, Nena Bowman4, Theodore F Reiss5, Tina V Hartert3,6, Wendell S Akers7,8, Donna L Seger2,4,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31056949      PMCID： PMC7314285          DOI： 10.1080/15563650.2019.1609686

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN： 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  5 in total

1.  Adverse events are rare after single-dose montelukast exposures in children.

Authors:  Donald H Arnold; Nena Bowman; Theodore F Reiss; Tina V Hartert; Donna L Seger
Journal:  Clin Toxicol (Phila)       Date:  2017-06-22       Impact factor: 4.467

2.  Acute asthma exacerbations, viral respiratory infections, and corticosteroid treatment.

Authors:  Donald Hayes Arnold
Journal:  Lancet Respir Med       Date:  2016-07-20       Impact factor: 30.700

Review 3.  Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections.

Authors:  B Knorr; S Holland; J D Rogers; H H Nguyen; T F Reiss
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

4.  A randomized controlled trial of intravenous montelukast in acute asthma.

Authors:  Carlos A Camargo; Howard A Smithline; Marie-Pierre Malice; Stuart A Green; Theodore F Reiss
Journal:  Am J Respir Crit Care Med       Date:  2002-11-27       Impact factor: 21.405

5.  Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.

Authors:  R J Sebaldt; J R Sheller; J A Oates; L J Roberts; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205
  5 in total
  2 in total

1.  Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review.

Authors:  Eleanor Grace Dixon; Charlotte Em Rugg-Gunn; Vanessa Sellick; Ian P Sinha; Daniel B Hawcutt
Journal:  BMJ Paediatr Open       Date:  2021-10-13

2.  Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.

Authors:  Donald H Arnold; Sara L Van Driest; Theodore F Reiss; Jennifer C King; Wendell S Akers
Journal:  J Clin Pharmacol       Date:  2020-09-22       Impact factor: 3.126
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.